InvestorsHub Logo
icon url

Rdunn88

05/19/20 8:57 AM

#297542 RE: centillion #297536

Yep, Compared to the other hyped treatments IPIX's market cap 42 million not bad, Leo needs to find a solution for human trial... Who is going to pay for it?
icon url

Zdubble17

05/19/20 8:58 AM

#297543 RE: centillion #297536

I’m not showing anything big in our way yet all the way up to .225
icon url

Justfactsmam

05/19/20 9:03 AM

#297549 RE: centillion #297536

You are correct:

"Brilacidin, in an in vitro experiment using VERO cells, reduced the viral titer (load) of SARS-CoV-2 by 75 percent after only 1 hour of preincubation prior to infection at a concentration of 10µM as compared to vehicle control.

These statistically significant lab results strongly support Brilacidin’s prophylactic treatment potential given the drug’s potent and rapid virucidal activity—a unique ability, different from any other known drug currently in development to treat COVID-19, to inactivate the novel coronavirus prior to host cell entry and subsequent viral replication."

"...the Company is prioritizing Brilacidin’s clinical development as a potential novel COVID-19 treatment, and thus is taking steps to rapidly advance Brilacidin into human trials."
icon url

TradingPro

05/19/20 9:12 AM

#297556 RE: centillion #297536

Remarkable results ! Any Company announcing something similar would be on a rocket ship. The whining here is nonsensical! SRNE CEO announced they have a cure before any real independent study ... look how that’s stock shot up!